Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG15 and/or UBP43
US8283113B2 · kind B2 · utility
1Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2008 |
| Grant date | Oct 9, 2012 |
| Priority date | — |
| Expiry date | Jan 20, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods of using compositions that induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins and enhance apoptosis of cancer (neoplastic) or pre-cancerous (pre-neoplastic) cells are provided. Methods for the prevention or treatment of cancer via administration of these compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.